According to GlobalData’s medical device pipeline database, 34 PTCA Drug Coated Balloon (DCB) Catheters devices are in various stages of development globally. GlobalData’s report PTCA Drug Coated Balloon (DCB) Catheters provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Of these devices, 25 are in active development, while the remaining 11 are in an inactive stage of development. There are eight products in the early stages of development, and the remaining 17 are in the late stages of development.
A Drug Coated Balloon (DCB) Catheter is an anti-restenotic drug coated PTCA balloon catheter intended to prevent re-narrowing of the coronary arteries. DCB Catheters provide fast, short-term, homogenous, local drug delivery. DCB catheters preserve the anatomy of the vessel, promote enhanced vessel healing, and reduce the need for prolonged dual anti-platelet therapy without leaving any metal behind. One unit refers to one PTCA DCB Catheter.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed PTCA Drug Coated Balloon (DCB) Catheters pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of PTCA Drug Coated Balloon (DCB) Catheters devices. Overall, most of these PTCA Drug Coated Balloon (DCB) Catheters pipeline devices are being developed by private entities.
Key players involved in the active development of PTCA Drug Coated Balloon (DCB) Catheters include Boston Scientific, Advanced NanoTherapies, B. Braun Interventional Systems, Orchestra BioMed, Medtronic, Shenzhen Salubris Pharmaceuticals, Vascular Nanotransfer Technologies, Spectranetics, MicroPort Scientific and OrbusNeich.
For a complete picture of the developmental pipeline for PTCA Drug Coated Balloon (DCB) Catheters devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.